Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36916659)

  • 1. Tumor-Targeting Nanoassembly for Enhanced Colorectal Cancer Therapy by Eliminating Intratumoral
    Li X; Ma Y; Xin Y; Ma F; Gao H
    ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36916659
    [No Abstract]   [Full Text] [Related]  

  • 2. Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer.
    Li X; Niu J; Deng L; Yu Y; Zhang L; Chen Q; Zhao J; Wang B; Gao H
    Acta Biomater; 2024 Jan; 173():432-441. PubMed ID: 37984629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering lauric acid-based nanodrug delivery systems for restoring chemosensitivity and improving biocompatibility of 5-FU and OxPt against
    Su M; Wen X; Yu Y; Li N; Li X; Qu X; Elsabahy M; Gao H
    J Mater Chem B; 2024 Apr; 12(16):3947-3958. PubMed ID: 38586917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remotely Controllable Supramolecular Nanomedicine for Drug-Resistant Colorectal Cancer Therapy Caused by Fusobacterium nucleatum.
    Yan X; Xin Y; Yu Y; Li X; Li B; Elsabahy M; Zhang J; Ma F; Gao H
    Small Methods; 2024 Mar; 8(3):e2301309. PubMed ID: 38018349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism.
    Ou S; Wang H; Tao Y; Luo K; Ye J; Ran S; Guan Z; Wang Y; Hu H; Huang R
    Front Cell Infect Microbiol; 2022; 12():1020583. PubMed ID: 36523635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer.
    Yamamoto S; Kinugasa H; Hirai M; Terasawa H; Yasutomi E; Oka S; Ohmori M; Yamasaki Y; Inokuchi T; Harada K; Hiraoka S; Nouso K; Tanaka T; Teraishi F; Fujiwara T; Okada H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1869-1876. PubMed ID: 33242360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
    Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
    J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient nuclear drug translocation and improved drug efficacy mediated by acidity-responsive boronate-linked dextran/cholesterol nanoassembly.
    Zhu JY; Lei Q; Yang B; Jia HZ; Qiu WX; Wang X; Zeng X; Zhuo RX; Feng J; Zhang XZ
    Biomaterials; 2015 Jun; 52():281-90. PubMed ID: 25818434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances on the treatment of
    Wang H; Hou X; Liu J; Yang C
    Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3670-3680. PubMed ID: 37805845
    [No Abstract]   [Full Text] [Related]  

  • 10. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota.
    LaCourse KD; Zepeda-Rivera M; Kempchinsky AG; Baryiames A; Minot SS; Johnston CD; Bullman S
    Cell Rep; 2022 Nov; 41(7):111625. PubMed ID: 36384132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium New Houttuyfonate Inhibits Cancer-Promoting
    Jia F; Yu Q; Zhao L; Shen Y; Guo H; He F
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551597
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
    Front Immunol; 2021; 12():658681. PubMed ID: 34093546
    [No Abstract]   [Full Text] [Related]  

  • 13. Size-tunable nanogels for cascaded release of metronidazole and chemotherapeutic agents to combat Fusobacterium nucleatum-infected colorectal cancer.
    Xie S; Wei L; Liu Y; Meng J; Cao W; Qiu B; Li X
    J Control Release; 2024 Jan; 365():16-28. PubMed ID: 37956925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium Nucleatum to Suppress Colorectal Cancer Progression.
    Jia F; Yu Q; Wang R; Zhao L; Yuan F; Guo H; Shen Y; He F
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674985
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yang Z; Ji G
    Oncol Lett; 2019 Aug; 18(2):975-982. PubMed ID: 31423156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Intratumoral
    Qu X; Yin F; Pei M; Chen Q; Zhang Y; Lu S; Zhang X; Liu Z; Li X; Chen H; Zhang Y; Qin H
    ACS Nano; 2023 Jun; 17(12):11466-11480. PubMed ID: 37201179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gene delivery system with autophagy blockade for enhanced anti-angiogenic therapy against Fusobacterium nucleatum-associated colorectal cancer.
    Li N; Yu Y; Chen Q; Niu J; Gao C; Qu X; Zhang J; Gao H
    Acta Biomater; 2024 Jun; ():. PubMed ID: 38838905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory and Cancer-Promoting Pathobiont
    Cavallucci V; Palucci I; Fidaleo M; Mercuri A; Masi L; Emoli V; Bianchetti G; Fiori ME; Bachrach G; Scaldaferri F; Maulucci G; Delogu G; Pani G
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma.
    Park HE; Kim JH; Cho NY; Lee HS; Kang GH
    Virchows Arch; 2017 Sep; 471(3):329-336. PubMed ID: 28597080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.